Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CMND
#5225
Clearmind Medicine Inc. Common Shares
1.1
3
-0.88%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-0.88%
Mudança mensal
-56.70%
Mudança em 6 meses
+10.78%
Mudança anual
-8.13%
Fechamento anterior
1.1
4
Open
1.1
3
Bid
Ask
Low
1.1
3
High
1.1
3
Volume
2
Mercados
Ações
Cuidados de saúde
CMND
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q4, 25
Total assets
—
—
Total liabilities
—
—
Total equity
—
—
Total liabilities & shareholders' equities
—
—
Total debt
—
—
Net debt
—
—
Notícias
Clearmind Medicine股价在I/IIa期试验安全性更新后下跌
Clearmind Medicine stock falls after Phase I/IIa trial safety update
Clearmind在酒精使用障碍药物试验中报告积极安全结果
Clearmind公布酒精使用障碍治疗试验的积极安全数据
Clearmind reports positive safety results in AUD drug trial
Clearmind reports positive safety data from AUD treatment trial
Clearmind Medicine股价在与Polyrizon达成鼻内给药协议后飙升
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
Clearmind与Polyrizon合作开发MEAI鼻内给药配方
Clearmind partners with Polyrizon to develop intranasal MEAI formulation
Polyrizon将开发Clearmind的MEAI药物鼻内给药配方
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug